Citadel Advisors’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$150K Buy
+70,200
New +$136K ﹤0.01% 11684
2025
Q4
Sell
-13,700
Closed -$20.1K 12777
2025
Q3
$20.1K Sell
13,700
-44,100
-76% -$65.5K ﹤0.01% 12488
2025
Q2
$103K Buy
57,800
+30,600
+113% +$45.4K ﹤0.01% 11325
2025
Q1
$39.7K Buy
27,200
+2,600
+11% +$5.08K ﹤0.01% 12546
2024
Q4
$37.6K Buy
24,600
+15,200
+162% +$24.7K ﹤0.01% 12662
2024
Q3
$17K Sell
9,400
-8,200
-47% -$15K ﹤0.01% 12904
2024
Q2
$29.6K Buy
17,600
+4,200
+31% +$8.75K ﹤0.01% 12290
2024
Q1
$34.6K Sell
13,400
-18,500
-58% -$43.1K ﹤0.01% 12550
2023
Q4
$63.2K Buy
31,900
+14,300
+81% +$12.5K ﹤0.01% 11528
2023
Q3
$16.4K Buy
17,600
+800
+5% +$880 ﹤0.01% 12780
2023
Q2
$19.2K Buy
+16,800
New +$14.6K ﹤0.01% 12761
2023
Q1
Sell
-44,800
Closed -$32.1K 14780
2022
Q4
$32.1K Buy
44,800
+11,200
+33% +$9.77K ﹤0.01% 12656
2022
Q3
$22K Buy
+33,600
New +$47.5K ﹤0.01% 12032
2022
Q2
Sell
-17,000
Closed -$55K 12966
2022
Q1
$55K Sell
17,000
-3,700
-18% -$12.5K ﹤0.01% 12729
2021
Q4
$89K Sell
20,700
-47,100
-69% -$255K ﹤0.01% 12826
2021
Q3
$405K Buy
67,800
+21,800
+47% +$146K ﹤0.01% 10379
2021
Q2
$381K Sell
46,000
-41,700
-48% -$339K ﹤0.01% 10686
2021
Q1
$753K Sell
87,700
-11,200
-11% -$124K ﹤0.01% 8782
2020
Q4
$1.2M Buy
98,900
+23,700
+32% +$327K ﹤0.01% 6408
2020
Q3
$1.22M Sell
75,200
-3,900
-5% -$63.9K ﹤0.01% 5666
2020
Q2
$1.19M Buy
79,100
+26,400
+50% +$356K ﹤0.01% 5510
2020
Q1
$383K Buy
52,700
+41,000
+350% +$322K ﹤0.01% 6906
2019
Q4
$70K Sell
11,700
-4,800
-29% -$24.7K ﹤0.01% 8672
2019
Q3
$70K Buy
16,500
+1,000
+6% +$3.74K ﹤0.01% 8611
2019
Q2
$60K Buy
+15,500
New +$54.8K ﹤0.01% 8670
2016
Q1
Sell
-5,000
Closed -$32K 6869
2015
Q4
$32K Buy
5,000
+2,700
+117% +$17.7K ﹤0.01% 7622
2015
Q3
$12K Sell
2,300
-1,000
-30% -$5.83K ﹤0.01% 8397
2015
Q2
$23K Buy
3,300
+2,500
+313% +$17.5K ﹤0.01% 8080
2015
Q1
$6K Sell
800
-800
-50% -$6.54K ﹤0.01% 8290
2014
Q4
$13K Sell
1,600
-1,900
-54% -$14.6K ﹤0.01% 8029
2014
Q3
$30K Sell
3,500
-1,500
-30% -$13.3K ﹤0.01% 7215
2014
Q2
$45K Buy
5,000
+4,200
+525% +$37.8K ﹤0.01% 6813
2014
Q1
$8K Buy
+800
New +$8.81K ﹤0.01% 7572

Other funds holding CGEN

Citadel Advisors's CGEN Position: Q1 2026 in Review

Citadel Advisors reduced its Compugen (CGEN) stake by 28% in Q1 2026, selling an estimated $86.8K and leaving 112,393 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #11013.

Citadel Advisors first reported a position in CGEN in Q1 2014 and has held it in 39 quarters since. The position peaked at $5.7M in Q1 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • Citadel Advisors held 112,393 shares of Compugen worth $239K as of Q1 2026.
  • Citadel Advisors sold 44,722 Compugen shares in Q1 2026, an estimated $86.8K.
  • Compugen made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11013 holding.
  • Citadel Advisors first reported a position in Compugen in Q1 2014 and has held it in 39 quarters since.
  • Citadel Advisors's Compugen position peaked at $5.7M in Q1 2020.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.